Green Thumb Industries Files Q3 2024 10-Q
Ticker: GTBIF · Form: 10-Q · Filed: 2024-11-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, earnings, cannabis, financials
TL;DR
**GTI Q3 10-Q filed. Financials for Sep 30, 2024 period out.**
AI Summary
Green Thumb Industries Inc. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and provides financial details for the nine months ended September 30, 2024, and comparative periods. Key financial items include retained earnings, cost of sales, and information related to subordinate voting shares and acquired debt.
Why It Matters
This filing provides investors with a detailed look at Green Thumb Industries' financial performance and position as of the end of the third quarter of 2024, crucial for understanding the company's operational health and future prospects.
Risk Assessment
Risk Level: medium — As a cannabis company, Green Thumb Industries operates in a highly regulated and evolving industry, which presents inherent risks.
Key Numbers
- Q3 2024 — Reporting Period (The 10-Q covers the third quarter of 2024.)
- 2024-09-30 — Period End Date (The financial information presented is as of this date.)
- 2024-11-08 — Filing Date (The date the 10-Q was officially submitted to the SEC.)
Key Players & Entities
- Green Thumb Industries Inc. (company) — Filer of the 10-Q
- 2024-09-30 (date) — End of reporting period for the 10-Q
- 2024-11-08 (date) — Filing date of the 10-Q
- DharmaPharmaceuticalsLlcMember (company) — Related entity mentioned in the filing
- 325 WEST HURON STREET, SUITE 700, CHICAGO, IL 60654 (address) — Company's business and mailing address
FAQ
What is the primary business of Green Thumb Industries Inc. according to the filing?
Green Thumb Industries Inc. is classified under AGRICULTURE PRODUCTION - CROPS [0100].
What is the filing date of this 10-Q report?
The 10-Q was filed on November 8, 2024.
What is the reporting period covered by this 10-Q?
The report covers the period ending September 30, 2024.
What is the company's business address?
The company's business address is 325 WEST HURON STREET, SUITE 700, CHICAGO, IL 60654.
Are there any specific subsidiaries or related entities mentioned?
Yes, DharmaPharmaceuticalsLlcMember is mentioned in relation to the company's structure.
From the Filing
0000950170-24-123669.txt : 20241108 0000950170-24-123669.hdr.sgml : 20241108 20241108060525 ACCESSION NUMBER: 0000950170-24-123669 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 93 CONFORMED PERIOD OF REPORT: 20240930 FILED AS OF DATE: 20241108 DATE AS OF CHANGE: 20241108 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Green Thumb Industries Inc. CENTRAL INDEX KEY: 0001795139 STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE PRODUCTION - CROPS [0100] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 981437430 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-56132 FILM NUMBER: 241437830 BUSINESS ADDRESS: STREET 1: 325 WEST HURON STREET STREET 2: SUITE 700 CITY: CHICAGO STATE: IL ZIP: 60654 BUSINESS PHONE: 312-471-6720 MAIL ADDRESS: STREET 1: 325 WEST HURON STREET STREET 2: SUITE 700 CITY: CHICAGO STATE: IL ZIP: 60654 10-Q 1 gtbif-20240930.htm 10-Q 10-Q false 0001795139 Q3 --12-31 0001795139 gtbif:DharmaPharmaceuticalsLlcMember srt:MaximumMember 2024-01-01 2024-09-30 0001795139 us-gaap:RetainedEarningsMember 2023-09-30 0001795139 gtbif:SubordinateVotingSharesMember gtbif:ShareCapitalMember 2023-12-31 0001795139 us-gaap:FairValueInputsLevel3Member 2024-06-30 0001795139 2024-07-01 2024-09-30 0001795139 gtbif:FloridaAndLllinoisMember 2024-01-01 2024-09-30 0001795139 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel1Member 2024-07-01 2024-09-30 0001795139 us-gaap:CostOfSalesMember 2023-07-01 2023-09-30 0001795139 gtbif:AcquiredDebtMember 2024-09-30 0001795139 us-gaap:NoncontrollingInterestMember 2024-06-30 0001795139 gtbif:SubordinateVotingSharesMember 2024-11-01 0001795139 us-gaap:FairValueInputsLevel1Member 2023-07-01 2023-09-30 0001795139 us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001795139 us-gaap:RetainedEarningsMember 2024-07-01 2024-09-30 0001795139 us-gaap:NotesReceivableMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001795139 gtbif:EquityClassifiedWarrantMember 2024-01-01 2024-09-30 0001795139 2017-01-01 2017-12-31 0001795139 2023-01-01 2023-12-31 0001795139 gtbif:SyndicatedCreditFacilitySeptemberElevenTwoThousandTwentyFourMember 2024-09-30 0001795139 gtbif:FinancialInstrumentsMember 2023-12-31 0001795139 gtbif:ContributedSurplusMember 2024-01-01 2024-09-30 0001795139 gtbif:DharmaPharmaceuticalsLlcMember gtbif:SubordinateVotingSharesMember 2024-02-15 2024-02-15 0001795139 gtbif:WarwickNewYorkMortgageNoteMember 2024-09-04 2024-09-04 0001795139 gtbif:DharmaPharmaceuticalsLlcMember 2024-02-15 2024-02-15 0001795139 us-gaap:WarrantMember 2024-07-01 2024-09-30 0001795139 gtbif:LiabilityClassifiedWarrantMember 2023-01-01 2023-12-31 0001795139 gtbif:ContributedSurplusMember 2023-01-01 2023-09-30 0001795139 gtbif:SuperVotingSharesMember gtbif:ConversionOfSuperVotingSharesMember 2024-01-01 2024-09-30 0001795139 gtbif:PrivatePlacementRefinancingWarrants1Member gtbif:EquityClassifiedWarrantMember 2023-12-31 0001795139 us-gaap:OtherCapitalizedPropertyPlantAndEquipmentMember 2023-12-31 0001795139 gtbif:FinancialInstrumentsMember 2024-09-30 0001795139 us-gaap:EquityMethodInvestmentsMember 2023-07-01 2023-09-30 0001795139 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001795139 us-gaap:FairValueInputsLevel3Member gtbif:FinancialInstrumentsMember 2023-12-31 0001795139 2023-09-30 0001795139 us-gaap:EquityMethodInvestmentsMember 2024-07-01 2024-09-30 0001795139 srt:MaximumMember 2024-01-01 2024-09-30 0001795139 us-gaap:MeasurementInputRiskFreeInterestRateMember gtbif:EquityClassifiedWarrantMember gtbif:DispensaryMortgageWarrantsMember 2024-09-30 0001795139 us-gaap:FairValueInputsLevel1Member 2024-09-30 0001795139 us-gaap:NotesReceivableMember 2024-01-09 0001795139 gtbif:SyndicatedCreditFacilitySeptemberElevenTwoThousandTwentyFourMember 2024-09-11 0001795139 us-gaap:OtherIntangibleAssetsMember 2024-09-30 0001795139 gtbif:PrivatePlacementRefinancingWarrantsMember gtbif:EquityClassifiedWarrantMember us-gaap:MeasurementInputExpectedTermMember 2024-01-01 2024-09-3